Allan C. Silber - Nov 17, 2022 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
Executive Chairman, Director, 10%+ Owner
Signature
/s/ William L. Demers, by Power of Attorney for Allan C. Silber
Stock symbol
PNT
Transactions as of
Nov 17, 2022
Transactions value $
$311,199
Form type
4
Date filed
11/21/2022, 04:52 PM
Previous filing
Mar 31, 2022
Next filing
Mar 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PNT Common Stock Purchase $166K +27.6K +0.65% $6.00 4.25M Nov 17, 2022 Direct
transaction PNT Common Stock Purchase $146K +22.4K +0.53% $6.50 4.27M Nov 18, 2022 Direct F1
holding PNT Common Stock 314K Nov 17, 2022 By Spouse
holding PNT Common Stock 538K Nov 17, 2022 Trustee F2
holding PNT Common Stock 4.04M Nov 17, 2022 Silber Holdings, Inc. F3
holding PNT Common Stock 71.7K Nov 17, 2022 Anglian Holdings, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.20 to $6.60, inclusive. The Reporting Person undertakes to provide to POINT Biopharma Global Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 Held in a trust for which the Reporting Person is the trustee.
F3 Silber Holdings, Inc. is a corporation controlled by the Reporting Person.
F4 Anglian Holdings, LLC is a limited liability company solely owned by the Reporting Person.